optogenetics
(2)
Integrated Biosciences
Integrated Biosciences is a Redwood City biotech founded in 2022 that fuses optogenetics, chemistry, and AI to discover small-molecule drugs for age-related diseases. Its optogenetic screening platform uses light to control cellular biology at millisecond and micron scale, generating clean data to train an explainable-AI drug-discovery engine. The company has published in Nature - including a new structural class of antibiotics - and raised $17.2M in seed funding led by Sutter Hill Ventures.
Felix Wong
Felix Wong is the co-founder and CEO of Integrated Biosciences, a Redwood City biotech using synthetic biology, optogenetics and explainable AI to discover small-molecule drugs for age-related disease. A physicist and mathematician by training with a Harvard PhD in applied physics, he led the team that reported the first new structural class of antibiotics discovered with explainable deep learning - published in Nature in 2023 - and pioneered the AI-driven discovery of senolytics. He was named to the Forbes 30 Under 30 in Healthcare and has authored more than 30 papers in journals including Nature, Science and Cell.